Biologics Facility Design & Pharmaceutical Regulatory Aspects - 2017

Website http://www.compliance4all.com/control/w_product/~product_id=501112LIVE?channel=mailer&camp=Webinar&A | Edit Freely

Category food and drug administration, fda drugs, drug administration, fda regulations, cgmp training, FDA Compliance Training, FDA compliance seminar, biologic, biologic drugs, biologics manufacturing, pharmaceutical companies

Deadline: April 03, 2017 | Date: April 04, 2017

Venue/Country: Fremont, U.S.A

Updated: 2017-02-24 18:44:17 (GMT+9)

Call For Papers - CFP

This course explores some of the best practices of pharmaceutical facility design with an emphasis on regulatory aspects. FDA and other global regulatory body requirements are discussed and the reasoning behind them.

Why should you Attend:

The attendee will learn what is important in facility design from the FDA and regulatory standpoint. The attendee will understand what FDA looks for during a facility inspection. The attendee will be able to minimize possible design errors which are difficult and expensive to fix post-build. The attendee will understand what FDA looks for in reviewing the facility design and the flow patterns.

Areas Covered in the Session:

Best design practices for Pharma facilities

Best design practices for biologics facilities

Regulatory compliance for Pharma and biologics facilities design

Flow patterns and cross contamination controls

Who Will Benefit:

Compliance Manager

Facility Manager

Validation Manager

Regulatory Manager

Design Team/Architects

Speaker Profile:

John R. Godshalk currently works for the Biologics Consulting Group as a Senior Consultant. John served as a Senior Review Biochemical Engineer and Lead cGMP inspector in the Division of Manufacturing and Product Quality at CBER, FDA. He contributed to formulation of FDA policy.

Contact Detail:

Compliance4All DBA NetZealous,

Phone: +1-800-447-9407

Email: supportcompliance4All.com